Andrea F. Wainer - Dec 17, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Dec 17, 2021
Transactions value $
-$679,050
Form type
4
Date filed
12/21/2021, 04:34 PM
Previous filing
Dec 15, 2021
Next filing
Dec 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $353K +7.5K +15.07% $47.00 57.3K Dec 17, 2021 Direct
transaction ABT Common shares without par value Sale -$1.03M -7.5K -13.09% $137.54 49.8K Dec 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -7.5K -34.52% $0.00 14.2K Dec 17, 2021 Common Shares 7.5K $47.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).